Product
Panitumumbab
1 clinical trial
1 indication
Indication
Colorectal CancerClinical trial
A Phase 0 Study of EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal CancerStatus: Recruiting, Estimated PCD: 2025-12-04